GET TOP RATED STOCK ALERTS ACTIVE TRADERS DEPEND ON
SIGN UP TODAY FOR FREE NEWS DRIVEN ALERTS
Denver, CO – January 9, 2024 – NxGen Brands, Inc. (OTCPK: NXGB) (“NxGen” or the “Company”), (www.nxgenbrands.com) successfully closes its “Mad House Innovations” acquisition. Mad House enjoyed explosive growth in 2023 and we invite the investment community to visit their corporate website to familiarize themselves with their exciting brand: “Mad House Innovations” (www.madhousesupps.com)
Mad House enjoyed $1m in revenues in its initial full year of operations, with growth forecasts from the Company expected to exponentially exceed that in 2024. Revenue share from direct-to-consumer channels represents approximately 35% of total sales, with additional revenue generated from ever-expanding distribution and retail relationships. The company believes that their cutting edge direct-to-consumer business model can be grown significantly throughout 2024 with the addition of marketing capital that NxGen is forecast to spend.
The Company recently announced that Mad House had licensed its products throughout Australia and New Zealand in a deal that is expected to net significant revenues this year as the brand picks up recognition throughout that market with its now emerging and very distinctive branding.
Joseph Lawanson, CEO of NxGen, stated, “Our brand boasts products such as ‘High dosed Pre-workout’, incredibly effective Amino’s, high-end testosterone, hardcore pump product and a great fat burner to provide you with an idea of our exciting product suite. With our now established presence in direct-to-consumer market as well as some of the top brick and mortar stores, we know that we can help the brand grow even more than it already has. We targeted a brand that is now firmly established in an upward trajectory, has a great social media following and can be blown up through social media advertising on Instagram™, TikTok™ and Facebook™. I am very excited to take this brand to the next level and I cannot wait to start sharing our month-over-month revenue growth with shareholders.”
NxGen recently announced that it had already completed on its first roll-up by acquiring ‘Storm Lifestyle Brands’ (www.stormlifestylebrands.com) which was launched in October 2021 to great fanfare at Olympia and has since gone from strength to strength with its Pre-Workout, Burn, Revive and Focus products. This new acquisition, the Company believes, will fit in to a different but equally fast-growing demographic and will, therefore, be a superb fit.
About NxGen Brands, Inc.
NxGen Holdings, Inc. is a publicly traded company under the symbol NXGB. The Company is building a profitable Nutritional Supplements company, comprising of several brands. www.nxgenbrands.com https://twitter.com/NxGen_Brands
Forward-Looking Statements
This press release may contain forward-looking statements, including information about management’s view of NxGen Brands, Inc.’s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of NxGen, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on NxGen’s future results. The forward-looking statements included in this press release are made only as of the date hereof. NxGen cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, NxGen undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by NxGen.
Corporate Contact:
ceo@nxgenbrands.com
www.nxgenbrands.com
Source: NxGen Brands, Inc.
The Technology Registered Allows A Smart Card That Has Been Designed To: Streamline Data Exchange and Availability For Healthcare Providers And Other Authorized Parties & To Verify Prescriptions that Includes Cannabis And Other Controlled Substances
Ft Lauderdale, FL – June 17,2021 – NxGen Brands Inc. (OTC: “NXGB”) (“NxGen Brands” or the “Company“), is pleased to announce the Company has entered into a definitive agreement to acquire 100% of HealthCard LLC (“HealthCard”), a technology company, that has a U.S. patent application pending for a patient-centric health recording and payment system. HealthCard, filed U.S. patent application number 15/944867 with the patent office on 2019-10-10 for System and Method for Patient-Centric Universal Health Recording and Payment.
Website: https://healthcard.co/
The Application is pending. https://uspto.report/patent/app/20190311791
The Technology can be implemented as follows:
HealthCard is a digital health card where users can view and share medical profile information and medical history on your mobile phone. The HealthCard allows for users to access their medical profiles and history all at once, prescriptions, pharmacy, doctors and latest COVID-19 updates and vaccines. The mobile app includes a database of users that can connect with any pre-authorized third party recipient.
Therefore, HealthCard can be integrated onto any on-demand thirty party delivery platform allowing RX prescriptions to be delivered directly to your doorstep. Users can request home delivery directly on the app from any local pharmacy.
Pending patent will be registered so Blockchain technology is included in the storage side of the server records. This ensures not only a HIPPA compliant secure medical backend that will be used as a universal registry to control medical and/or cannabis related information. The secure card can be implemented as a solution for real time update of user’s databases in real time across the Internet in a secure format. The system will allow for immediate identification of system abuse while documenting the consumption of the patient. Access to the medical record by authorized viewer in real time adds to the benefits that the infrastructure allows to be accomplished. Also, will avoid any system misuse while ensuring locally and abroad, an authorized database which is patient driven, doctor controlled and government ensuring transparency and compliance at all levels of the structure. Integration of a digital form of the ID card will allow authentication via biometrics, confirmation of location via GPS, interaction via camera if required and overall access in real time to critical information relating to the health of the user.
Angel Burgos, the Company CEO said: “This system can be incorporated both as a smart ID card with NFC/Infrared and other technologies or simply pair it with a smart phone with included capabilities and that alone would be enough to use the technologies behind the solution. In addition, this can be integrated at corporate level and has governmental applications which can be designed with our core technology structure. We can with the endorsement of corporate or government, setup a third-party authentication system so business or government can “verify” vaccine status in a secure and unassuming format without exposing additional information.”
About NxGen Brands, Inc.
NxGen Brands Inc. is a multifaceted public company comprised of essential business industries that serve various market segments. Our competence lies in the establishment of brands with specific target segments while associating backend collaboration tactics to maximize our growth and expansion. In alliance with our regional partners throughout the US, we seek to establish partnerships within the nationwide networks of related businesses in the industry, in anticipation of required marketplace needs.
The breakdown of our primary core business model includes, but is not limited to, Health and Wellness products, secure delivery and logistic services, CBD and Cannabis products, GPS tracking technologies, remote authentication, and validation and secure block chain outputs. Our in-house ability and experience to engineer, design, manufacture, develop, integrate, and go to market within the company structure allows us to streamline processes and to determine the most cost-effective way to establish the proposed market share.
About HealthCard, LLC
HealthCard is a biomedical developer of topical drug technologies targeting the OTC pharmaceutical and cosmetic applications, and it’s innovative, patent pending technology utilizing blockchain as a decentralized but secure storage format is targeting the multi-billion dollar healthcare industry, empowering patients and providers to make an impact in healthcare and deliver value based care. Technologies can be implemented for both private providers and governmental standardization of health record management.
Website: https://healthcard.co/
For more information on “NXGB” the corporation, please visit the corporate website at https://www.nxgenbrands.com.
To be added to the Company investor email list, please email info@nxgenbrands.com with “NXGB” in the subject line.
FORWARD-LOOKING STATEMENTS:
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/NXGB/disclosure
Contact:
info@nxgenbrands.com
Phone: (888) 315-6339
SOURCE NxGen Brands Inc.
The Technology Largely Involves Advanced GPS Tracking And Associated Products/Uses
Ft Lauderdale, FL – January 22, 2020 – NxGen Brands Inc. (OTCPK: NXGB) (“NXGB” or the “Company“), is pleased to announce that it has acquired an exclusive worldwide license for various tracking and observation technologies and their related products and services. The Company can utilize these technologies to further augment their newly announced digital supply chain & blockchain cannabis dispensary delivery services market app. It also utilizes these ready-to-market solutions as independent apps and services, bringing more potential revenues to the Company.
The Licensed Technology from MyIAD includes:
- a) PTYpass — A contactless biometric human tracking for travel COVID
- b) MyIAD GPS Solutions. — A GPS Tracking & Monitoring Solution
- c) MyIAD SOS. — A satellite Observation System.
- c) MyIAD Law Solutions — A House Arrest & Domestic Violence Solution.
- d) MyIAD IP Solutions — A Analytic Security & Monitoring Solution.
- e) MyIAD Solar Solutions — A Solar & Green Based IP Solutions.
- f) MonitorINMATES — A Real Time Offender Management & Tracking System.
- g) MonitoREOS — A Real Time Offender Management & Tracking System. (Latino Markets); and
- h) Heart Watch — Real Time Management & Tracking System for Heart. (Watch approved hardware)
The ten (10) year licenses were acquired from MyIAD Corporation, a Wyoming Corporation (Licensor) in return for stock and a five percent (5%) royalty. The full agreement can be viewed on the OTC Markets website. https://www.otcmarkets.com/stock/NXGB/disclosure
Angel Burgos, the Company CEO said: “I founded and personally developed the above products and services between 2010 thru 2017, before becoming NxGen’s CEO, and envisioned that when the time was right to expand the Company’s development and next generation products and services, I would grant the Company an exclusive license. The recent announcement of our entry into the digital supply chain & blockchain cannabis dispensary delivery services market through our partnership with our partner, Bengala Technologies, LLC a nationally recognized developer in this field, made this the right time. The Company believes that this asset in conjunction with my past experience in tracking electronic monitored citizens in house arrest and currently the program running in Tocumen International in Panama as the center application for contact tracing for all arrivals which average 486K citizens being monitored should help shorten the time it will take us to launch the dispensary MJ platform, and can generate revenues for the Company along the way with the entry into additional fields.”
For more information on MyIAD go to: https://www.myiad.com – www.monitorinmates.com – https://pytpass.app and – www.monitoreos.net
About NxGen Brands, Inc.
NxGen Brands, Inc. owns a wholly owned subsidiary NxGen Brands LLC dba: LeafyWell. Our websites can be viewed at www.leafywell.com and www.nxgenbrands.com. Our pursuit is to leverage equity, acquire, merge and or joint venture with early-stage companies in emerging industries, to stimulate growth, cash flow and increase broader distribution channels.
Our newly added proprietary and licensed formulated products included in the commercial, industrial, and residential cleaning supplies, disinfectants, and sanitizers can be seen at www.nxgenbrands.com or www.leafywell.com and for more information or to make bulk purchases, please contact sales@nxgenbrands.com.
For more information on “NXGB” the corporation, please visit the corporate website at https://www.nxgenbrands.com.
About Bengala Technologies:
Bengala Technologies LLC, achieved excellence in the field of blockchain consulting and development by creating and deploying custom decentralized blockchain and supply apps including Supply Chain, Blockchain and Smart Contract Development applications.
For more information on Bengala Technologies LLC go to: https://bengalatech.io
To be added to the Company investor email list, please email info@nxgenbrands.com with “NXGB” in the subject line.
FORWARD-LOOKING STATEMENTS:
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/NXGB/disclosure
Contact:
info@nxgenbrands.com
Phone: (888) 315-6339
SOURCE NxGen Brands Inc.
The Global Medical & Recreational Legal Marijuana Market Size Is Expected to Reach USD 73.6 Billion By 2027; The US Will Account for About 73% Of the Global Cannabis Dispensing Market In 2024
Ft Lauderdale, FL – January 12, 2021 – NxGen Brands Inc. (OTCPK: NXGB) (“NXGB” or the “Company“), is pleased to announce that it has partnered with a digital supply chain & blockchain developer to allow the Company to enter into the rapidly growing U.S. cannabis dispensary delivery services market. The partner, Bengala Technologies LLC, is a nationally recognized developer in this field located in West Palm Beach, Florida.
The partnership with Bengala Technologies LLC (https://bengalatech.io), will allow the company to deliver its own proprietary brands of flower and Leafywell™ products, and will allow it to create a national network to provide delivery services for dispensaries across the country. The sale and delivery for recreational and medicinal cannabis is projected to see explosive growth through 2027 reaching $73.6B, and this transaction allows the Company to be at the forefront of the projected wave.
A cannabis dispensary delivery provider must adhere to multiple local, state and national regulations, including licensees, transportation and delivery requirements. The blockchain digital supply chain technology apps to be developed for the Company will address these issues and allow the Company to be compliant and adhere to the regulations across all national markets.
“Angel Burgos, the Company CEO said: “Cannabis companies that provide delivery services – including delivery operators and retailers – are seeing a deluge of orders as customers stock up on marijuana products in the wake of current pandemic concerns. Our hope is that, after opening projected operations in California, Michigan and we will then do the same in Florida. Initially for medicinal delivery services while awaiting pending recreational approval. Internal research has demonstrated that faster delivery can spur increased sales and help to increase revenues.”
Bengala Technologies LLC, achieved excellence in the field of blockchain consulting and development by creating and deploying custom decentralized blockchain and supply apps including Supply Chain, Blockchain and Smart Contract Development applications.
Mr. Arnaldo Detres, the Managing Director of Bengala Technologies LLC said: “There are so many variants of regulations in the cannabis delivery services and blockchain can meet these regulatory and supply side needs from available inventory and supply to delivery for the proposes of local authentication and validation rules. Blockchain can enable more transparent and accurate end-to-end tracking in the supply chain organizations can digitize physical assets and create a decentralized immutable record of all transactions, making it possible to track assets from production to delivery to end user.”
According to a recent report by ArcView Market Research and BDS Analytics, the global licensed dispensary sales of cannabis will reach $40.6 billion by 2024, registering a CAGR of 24.5%. The US will account for about $30 billion or 73% of the global cannabis dispensing market in 2024. It is projected that by 2024, the retail dispensing sales of legal recreational cannabis will cross $26.7 billion, whereas the revenue generated from the sales of medical cannabis will reach $13.9 billion. The retail sales of THC containing products from licensed dispensaries across the US will feature growth of nearly 300%, i.e., from $8.4 billion in 2018 to more than $24.7 billion in 2024.
The partnership will allow NxGen Brands to produce and ship via its proprietary direct delivery network with the software and technical technologies created by Bengala Technologies LLC, both existing CBD based SKU’s and cannabis-based products. This will allow the Company to market throughout the states which have recreational and/or medical and continue to establish and grow the Leafywell™ branded products. The transaction also aims at interacting with other companies and expanding the licensing deal possible focusing on combining its brands with medical licensed producers, to shape how future cannabis brands operate in the United States.
For more information, customers can sign up at www.nxgenbrands.com or www.leafywell.com to be among the first notified when our offering becomes available.
For more information on Bengala Technologies LLC go to: https://bengalatech.io
About NxGen Brands, Inc.
NxGen Brands, Inc. is a diversified portfolio company compromising business lines directed at serving consumer products demands in a variety of markets and across a broad spectrum of industries. NxGen Brands, Inc. maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency protocols. NxGen Brands, Inc. is partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space. In collaboration with our partners, we seek to provide an infrastructure that meet anticipated marketplace needs on both large and small scale volume levels. One of our principal aims is our pursuit to leverage equity, acquire, merge and or joint venture with early-stage companies in emerging industries, to stimulate growth, cash flow , and increase broader distribution channels.
NxGen Brands, Inc created and owns a subsidiary, NxGen Brands LLC dba: Leafywell™. Our websites can be viewed at www.leafywell.com and www.nxgenbrands.com. NxGen Brands Inc. newly added proprietary and licensed formulated products included in the commercial, industrial, and residential cleaning supplies, disinfectants, and sanitizers can be seen at http://www.nxgenbrands.com or www.leafywell.com and for more information or to make bulk purchases, please contact sales@nxgenbrands.com.
For more information on “NXGB” the corporation, please visit the corporate website at https://www.nxgenbrands.com.
To be added to the Company investor email list, please email info@nxgenbrands.com with “NXGB” in the subject line.
FORWARD-LOOKING STATEMENTS:
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at: https://otcmarkets.com/stock/NXGB/disclosure
Contact: info@nxgenbrands.com Phone: (888) 315-6339
SOURCE NxGen Brands Inc.
Davie, FL – September 2, 2020 – NxGen Brands Inc. (OTCPK: NXGB), announces that it has added various new CBD-based products to manage various sports and lifestyle pain and injuries under the LeafyWell brand. These products will be added to our existing line of CBD based products. Each product is certified THC-free and made with 100% natural, organic hemp.
The active lifestyle products combine various of the most effective topical pain-reducing ingredients available in over-the-counter formulations. The end products that are available are in the form of creams, roll on and sprays with the inflammation fighting properties of CBD. The formulation alleviates relief for people with active sports orientated lifestyles.
Consumer feedback as well as evidence from medical studies, have shown that CBD and other cannabinoids act in ways like other anti-inflammatory substances. By combining non-psychoactive CBD with other natural ingredients, including the cooling and relaxing sensation of menthol, can help all users of the products, potentially reducing the pain and inflammation associated with muscle aches and strains.
“We have tested these products internally and feel that these products should be made available to the public. With this stated, we have developed a product line which we anticipate will be available in stores through distribution chains and online within the next 45-90 days before the holidays. This will introduce high quality CBD to markets alternate to the traditional stores in sizes that start in one ounce. Now that CBD is legal for the public, we are looking to secure a space in the retail marketplace. When you feel good, you are more likely to keep a healthy lifestyle and stay active,” said Angel Burgos, the President & CEO of NxGen Brands Inc.
NxGen Brands’ CBD products are for people who have an active lifestyle, are into sports, and/or are in demanding jobs. If you encounter muscle stiffness or pain, our CBD products may be able to help you feel better. From balms, lotions, roll-on gels, and bath bombs to tinctures, edibles, and capsules, LeafyWell has created products that work to accommodate the needs and requirements of most of our customers. All the CBD in our products comes from hemp grown and harvested in the United States.
Additionally, LeafyWell specializes in the manufacturing and distribution of full-spectrum CBD (Cannabidiol) and Cannabigerol (CBG) products and product lines including tinctures, creams, lotions, edibles as well as a full line of pet products available online and at select retailers nationwide. To see the LeafyWell brand products, visit www.LeafyWell.com, call (888) 315-6339, or email support@LeafyWell.com.
About NxGen Brands, Inc.
NxGen Brands, Inc. owns a wholly owned subsidiary NxGen Brands LLC 100% dba: LeafyWell. Our websites can be viewed at www.leafywell.com and www.nxgenbrands.com. Our pursuit is to leverage equity, acquire, merge and or joint venture with early-stage companies in emerging industries, to stimulate growth, cash flow and increase broader distribution channels.
Our newly added proprietary and licensed formulated products included in the commercial, industrial, and residential cleaning supplies, disinfectants, and sanitizers can be seen at www.nxgenbrands.com or www.leafywell.com and for more information or to make bulk purchases, please contact sales@nxgenbrands.com.
For more information on “NXGB” the corporation, please visit the corporate website at https://www.nxgenbrands.com.
To be added to the Company investor email list, please email info@nxgenbrands.com with “NXGB” in the subject line.
FORWARD-LOOKING STATEMENTS:
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the OTC Markets Group Inc. Our public filings with the OTC Markets Group Inc are available from commercial document retrieval services and at the website maintained by the OTC Markets at https://www.otcmarkets.com/stock/NXGB/disclosure
Contact:
info@nxgenbrands.com
Phone: (888) 315-6339
SOURCE NxGen Brands Inc.
About NxGen Brands Inc.
NxGen Brands, Inc. (NXGB) is a publicly traded holding company in up-trending industries and utilizes technologies targeting economies of scope with subsidiaries focused on multiple verticals with strategic relationships.
We are committed to working with health professionals to expand the awareness of CBD, providing high-grade CBD and CBG oil, and producing a full product line of high-quality, reliable CBD and CBG products.
In light of the current global pandemic, NxGen Brands has expanded their product lines to include Personal Protective Equipment (PPE) consisting of masks and gloves cleaners and concomitantly, an additional complete product line includes disinfectants, cleaners, and sanitizers. As part of this strategic move, this product line includes environmentally friendly and EPA registered cleaning products suitable for commercial, industrial, and residential applications.
The Company currently distributes CBD, CBG, PPE, and disinfectant, cleaning, and sanitizing products to retail, wholesale, and white label customers. We are a veteran owned company.
LEAFYWELL CBD Products
Our products are 100% all natural, 99%+ Pure CBD and manufactured in controlled, certified labs. Our mission is your health.
Personal Protection Equipment
We provide a valuable solution of approved PPE products to governments and commercial sectors.
Commercial Cleaning Products
We provide a safe, sustainable product protecting our environment. 100% Dissolvable Concentrated Liquid
Leafywell products are 100% all natural, 99%+ Pure CBD and manufactured in controlled, certified labs. Every one of our products are subjected to stringent quality control tests which are thoroughly monitored from its original extraction. We are an American business based in Florida, and all of our products are farmed, analyzed, and produced in the USA. Our products come backed with a 3rd party testing certification.
Our products provide a more natural and holistic approach to health and wellness. Leafywell distributes CBD, CBG, PPE, and disinfectant, cleaning, and sanitizing products to retail, wholesale, and white label customers. We are a veteran owned company.
Leafywell CBD’s
* Salves
* Creams
* Full Spectrum CBD OIls
* CBG Oils
* Bath & Body
* Edibles
* THC Free CBD Oils
* Chapstick
* Coffee
Source: https://nxgenbrands.com/
Disclaimer
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated thirty five hundred dollars for NxGen Brands Inc. current news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF NxGen Brands Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.